iRhythm Technologies Inc. (NASDAQ: IRTC) announced results from the AMALFI clinical trial showing that home-based cardiac monitoring using its Zio ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE